Although the incidence of cervical cancer has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination, cervical cancer remains the second highest cause of cancer mortality among women in low- and middle-income countries. There are different treatments for the disease, including surgery, radiotherapy and chemotherapy. In a recent clinical practice statement, clinicians explore therapies for cervical cancer by treatment setting, quality of life, financial toxicity, and disparities associated with the disease. Read more at cinj.org.
Eugenia Girda, MD, FACOG - gynecologic oncologist in the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health